Cadila Healthcare’s arm enters into BTA with Zenex Animal Health

12 May 2021 Evaluate

Cadila Healthcare’s wholly owned material subsidiary -- Zydus Animal Health and Investment (ZAHL) has entered into a Business Transfer Agreement (BTA) and other Ancillary Agreements (together Definitive Agreements) for disposal of its Animal Healthcare Established Markets Undertaking  (having animal healthcare business in India and certain other countries) to Zenex Animal Health India (formerly known as Nutrizvit Animal Health India), by way of a slump sale, without values being assigned to the individual assets and liabilities on debt free and cash free basis, subject to certain closing date adjustments specified in the BTA, with effect from such date, in such manner and on such terms and conditions, as specified in the Definitive Agreements.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

1013.75 14.15 (1.42%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.